CAVIN1
Basic information
Region (hg38): 17:42402449-42423256
Previous symbols: [ "PTRF" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 6.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_012232.6 | NP_036364.2 | 2 | yes | - |
ENST00000357037.6 | ENSP00000349541.4 | 2 | yes | - |
ENST00000870236.1 | ENSP00000540295.1 | 2 | - | - |
ENST00000944722.1 | ENSP00000614781.1 | 2 | - | - |
Phenotypes
GenCC
Source:
- congenital generalized lipodystrophy type 4 (Strong), mode of inheritance: AR
- lipodystrophy (Definitive), mode of inheritance: AR
- congenital generalized lipodystrophy type 4 (Strong), mode of inheritance: AR
- Berardinelli-Seip congenital lipodystrophy (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Lipodystrophy, congenital generalized, type 4 | AR | Cardiovascular | Among other manifestations, individuals may demonstrate cardiac arrhythmias, and appropriate surveillance and management may be beneficial | Cardiovascular; Endocrine; Gastrointestinal; Musculoskeletal | 12116229; 18698612; 19726876; 20300641; 20684003 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (62 variants)
- not_provided (53 variants)
- Congenital_generalized_lipodystrophy_type_4 (39 variants)
- CAVIN1-related_disorder (14 variants)
- Monogenic_diabetes (6 variants)
- Congenital_generalized_lipodystrophy (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAVIN1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_012232.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 23 | 1 | 29 | ||
| missense | 1 | 67 | 7 | 75 | ||
| nonsense | 1 | 3 | 4 | |||
| start loss | 0 | |||||
| frameshift | 8 | 3 | 11 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 10 | 7 | 73 | 30 | 1 |
Highest pathogenic variant AF is 0.000017379947
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CAVIN1 | protein_coding | protein_coding | ENST00000357037 | 2 | 21066 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125730 | 0 | 17 | 125747 | 0.0000676 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.38 | 195 | 257 | 0.759 | 0.0000196 | 2482 |
| Missense in Polyphen | 116 | 153.97 | 0.75337 | 1540 | ||
| Synonymous | 1.08 | 108 | 123 | 0.876 | 0.00000997 | 806 |
| Loss of Function | 1.40 | 5 | 9.71 | 0.515 | 4.26e-7 | 137 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000206 | 0.000206 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000545 | 0.0000527 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in caveolae formation and organization. Essential for the formation of caveolae in all tissues (PubMed:18056712, PubMed:18191225, PubMed:19726876). Core component of the CAVIN complex which is essential for recruitment of the complex to the caveolae in presence of calveolin-1 (CAV1). Essential for normal oligomerization of CAV1. Promotes ribosomal transcriptional activity in response to metabolic challenges in the adipocytes and plays an important role in the formation of the ribosomal transcriptional loop. Dissociates transcription complexes paused by DNA-bound TTF1, thereby releasing both RNA polymerase I and pre-RNA from the template (By similarity). {ECO:0000250|UniProtKB:O54724, ECO:0000269|PubMed:18056712, ECO:0000269|PubMed:18191225, ECO:0000269|PubMed:19726876}.;
- Disease
- DISEASE: Congenital generalized lipodystrophy 4 (CGL4) [MIM:613327]: A disorder characterized by the association of congenital generalized lipodystrophy with muscular dystrophy and cardiac anomalies. Congenital generalized lipodystrophy is characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. {ECO:0000269|PubMed:19726876, ECO:0000269|PubMed:20684003}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Gene expression (Transcription);RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.265
Intolerance Scores
- loftool
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Zebrafish Information Network
- Gene name
- cavin1a
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- convolute
Gene ontology
- Biological process
- transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;rRNA transcription;positive regulation of cell motility
- Cellular component
- nucleus;nucleoplasm;cytoplasm;mitochondrion;endoplasmic reticulum;cytosol;plasma membrane;caveola;protein-containing complex;intracellular membrane-bounded organelle;membrane raft
- Molecular function
- RNA binding;protein binding;rRNA primary transcript binding;identical protein binding